RevOpsis Therapeutics: Funding, Investors & Team (Oct 2026)
RevOpsis Therapeutics is focused on tackling vision loss by leveraging its unique bispecific Surrobody platform to target a variety of eye-related conditions with potential therapeutic treatments. Established in 2022, the company is headquartered in Springfield, Illinois, USA.
RevOpsis Therapeutics has raised $18.7M across 4 funding rounds on record, the most recent a Seed announced in Sep 2025.
RevOpsis Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
RevOpsis Therapeutics Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
RevOpsis Therapeutics raised $7.9M in an undisclosed round announced in Aug 2023.
8 months later, a Seed of $9.0M was announced in Apr 2024.
6 months later, an undisclosed round of $1.8M was announced in Oct 2024.
11 months later, a Seed was announced in Sep 2025 with no disclosed amount.
RevOpsis Therapeutics Founders and Leadership Team
Contact details for the RevOpsis Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →RevOpsis Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like RevOpsis Therapeutics in Biotechnology and Springfield
Companies Similar to RevOpsis Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
RevOpsis Therapeutics Funding FAQs
What does RevOpsis Therapeutics do?
RevOpsis Therapeutics is focused on tackling vision loss by leveraging its unique bispecific Surrobody platform to target a variety of eye-related conditions with potential therapeutic treatments. Established in 2022, the company is headquartered in Springfield, Illinois, USA.
How much funding has RevOpsis Therapeutics raised?
RevOpsis Therapeutics has raised $18.7M across 4 rounds on record.
When did RevOpsis Therapeutics last raise funding?
RevOpsis Therapeutics' most recent funding round on record was announced in Sep 2025. The amount was not disclosed.
Who founded RevOpsis Therapeutics?
FundedIQ lists Ramanath Bhandari (Founder) at RevOpsis Therapeutics.
Where is RevOpsis Therapeutics headquartered?
RevOpsis Therapeutics is based in Springfield, Illinois, United States.
How many employees does RevOpsis Therapeutics have?
RevOpsis Therapeutics is in the 1-10 employee band.
About FundedIQ's RevOpsis Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RevOpsis Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.